• Log in
  • Home
  • EABE
  • My Articles
  • Submit an Article
  • Online Volumes
  • Older issues
  • Contact us

Diabetic Cardiomyopathy: What’s new and novel therapies

September 1, 2019 · Issue 2
Print Article
Citation
  • Email
  • Tweet

Authors

  • Nikolaos Nikolopoulos Department of Internal Medicine, General Oncological Hospital ‘Agioi Anargiroi’, Kifisia, Athens.
  • Tsalkatidou Despoina Faculty of General Medicine, Comenius University in Bratislava.
  • Theodoros Katsikas Department of Internal Medicine, General Oncological Hospital ‘Agioi Anargiroi’, Kifisia, Athens.
  • Katerina Gianneli Department of Internal Medicine, General Oncological Hospital ‘Agioi Anargiroi’, Kifisia, Athens.
  • Andreas Kalliakmanis Department of Internal Medicine, General Oncological Hospital ‘Agioi Anargiroi’, Kifisia, Athens.

Abstract

Diabetic cardiomyopathy is a cardiac dysfunction with a prevalence of 12% in diabetic patients. The precise pathophysiological mechanism leading to the development of thisspecific type of cardiomyopathy is complex and not completely yet known. Since 1972, when the definition of diabetic cardiomyopathy wasintroduced, until today significant progress has been made in its diagnosis and treatment. The earlier the diagnosis is made by using mainly echocardiography, the higher the chances of reversing the progression of the disease to overt failure. Thisreview aimsto summarize the various diagnostic methods, current prevention approaches, and innovative treatment strategies.

Keywords: Cardiac dysfunction, diabetes mellitus, diabetic cardiomyopathy

  • About Annotum